A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
- Status
- RECRUITING
- Phase
- N/A
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases
- Status
- SUSPENDED
- Phase
- EARLY_PHASE1
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy
- Status
- RECRUITING
- Phase
- NA
A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
REACH (Restore Energy, Activity Can Help) Lupus Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
REACT-01: Reversing Autoimmunity Through Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE1
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
- Status
- RECRUITING
- Phase
- N/A
Intervention to Improve Communication and Medication Adherence in Lupus
- Status
- RECRUITING
- Phase
- NA
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2)
- Status
- WITHDRAWN
- Phase
- PHASE3
Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects
- Status
- RECRUITING
- Phase
- PHASE1
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus
- Status
- WITHDRAWN
- Phase
- PHASE1
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1